Systemic lupus erythematosus: association with psoralen--ultraviolet-A treatment of psoriasis.
Systemic lupus erythematosus (SLE) developed in as 23-year-old woman with psoriasis during treatment with psoralen-ultraviolet-A (PUVA). The connective tissue disease was characterized by an erythematous rash, hair loss, nephritis, splenomegaly, seizures, and coma. Serum antinuclear antibodies were present in high titer, and hypocomplementemia developed. Antibodies to native or ultraviolet-irradiated DNA were not demonstrated. While the association of psoriasis and lupus may have been fortuitous, the temporal relationships suggest that PUVA treatment in this case may have been of pathogenetic importance in the development of the connective tissue disease.
D000328:Adult; D000906:Antibodies; D004247:DNA / Q000276:immunology; D005260:Female; D005363:Ficusin / Q000627:therapeutic use*; D011564:Furocoumarins / Q000627:therapeutic use*; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000209:etiology* / Q000276:immunology; D010778:Photochemotherapy / Q000009:adverse effects*; D011565:Psoriasis / Q000188:drug therapy*
D000906:Antibodies; D011564:Furocoumarins; D004247:DNA; D005363:Ficusin